Ameriprise’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $106K | Buy |
91,195
+78,578
| +623% | +$91.2K | ﹤0.01% | 3848 |
|
|
2025
Q1 | $20.1K | Sell |
12,617
-134,056
| -91% | -$213K | ﹤0.01% | 3950 |
|
|
2024
Q4 | $444K | Buy |
+146,673
| New | +$444K | ﹤0.01% | 3542 |
|
|
2023
Q4 | – | Sell |
-166,004
| Closed | -$3.33M | – | 3991 |
|
|
2023
Q3 | $3.33M | Sell |
166,004
-36,675
| -18% | -$736K | ﹤0.01% | 2573 |
|
|
2023
Q2 | $5.72M | Sell |
202,679
-64,626
| -24% | -$1.82M | ﹤0.01% | 2240 |
|
|
2023
Q1 | $4.6M | Buy |
267,305
+48,341
| +22% | +$831K | ﹤0.01% | 2381 |
|
|
2022
Q4 | $4.41M | Buy |
218,964
+34,515
| +19% | +$695K | ﹤0.01% | 2372 |
|
|
2022
Q3 | $3.99M | Buy |
184,449
+10,905
| +6% | +$236K | ﹤0.01% | 2372 |
|
|
2022
Q2 | $4.88M | Buy |
+173,544
| New | +$4.88M | ﹤0.01% | 2295 |
|